| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | Chief Financial Officer
2 companies
Graham Juan serves as a Chief Financial Officer at KYNB and has filed Form 4s across 2 companies. Across recent SEC filings that breaks down to 1 buy and 10 sells. Those positions are worth an estimated $1.3M at current prices.
Historically, Graham Juan's trades have earned a strong insider score of 81/100 across 7 rated trades. Over a 12-month horizon, 100.0% of those trades were profitable, with an average 12-month return of +92.6%.
The biggest single holding is KYNB (~$1.2M) as Chief Financial Officer. The recent filings there lean toward selling, a net 17,375 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 28, 2025 | CATX Perspective Therapeutics, Inc. | Chief Financial Officer | Buy | 33,333 | $2.25 | $74,945.92 | +1,649% | +64.5% | +85.0% | |
| Jun 7, 2023 | KYNB Fibrogen Inc | Chief Financial Officer | Sell | 1,785 | $16.99 | $30,320.02 | -1.2% | -93.8% | -93.1% | |
| Mar 10, 2023 | KYNB Fibrogen Inc | Chief Financial Officer | Sell | 7,661 | $20.54 | $157,366.71 | -2.5% | -11.6% | -91.1% | |
| Dec 12, 2022 | KYNB Fibrogen Inc | Chief Financial Officer | Sell | 2,188 | $14.64 | $32,038.40 | -2.0% | +39.3% | -95.7% | |
| Dec 8, 2022 | KYNB Fibrogen Inc | Chief Financial Officer | Sell | 5,741 | $14.89 | $85,497.58 | -5.4% | +39.7% | -95.9% |